DEXAMETHASONE SODIUM PHOSPHATE

DEXAMETHASONE SODIUM PHOSPHATE was reported 10391 times

DEXAMETHASONE SODIUM PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 16 0.6154
1 RETRO-ORBITAL NEOPLASM 16 0.3019
2 CHOROIDITIS 67 0.1791
3 NEUROBLASTOMA RECURRENT 15 0.0739
4 NEGATIVE PRESSURE PULMONARY OEDEMA 7 0.0714
5 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 19 0.0414
6 TRIPLE NEGATIVE BREAST CANCER 24 0.0357
7 BETA 2 MICROGLOBULIN INCREASED 9 0.0345
8 SPLENIC ABSCESS 14 0.0344
9 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 10 0.0341
10 BILE ACIDS INCREASED 6 0.0339
11 LIGHT CHAIN ANALYSIS ABNORMAL 7 0.0337
12 BLOOD CHOLINESTERASE DECREASED 9 0.0328
13 CENTRAL HYPOTHYROIDISM 10 0.0302
14 PARAPROTEINAEMIA 9 0.0290
15 COLONY STIMULATING FACTOR THERAPY 6 0.0290
16 MONOCLONAL GAMMOPATHY 17 0.0271
17 ALLERGY TEST POSITIVE 12 0.0265
18 ANTITHROMBIN III DECREASED 7 0.0256
19 RENAL VEIN THROMBOSIS 17 0.0251
20 CEREBRAL VENOUS SINUS THROMBOSIS 21 0.0249
21 HYPOPROTEINAEMIA 40 0.0211
22 RADIATION NECROSIS 12 0.0209
23 HYPOCHLORAEMIA 23 0.0196
24 LEFT VENTRICULAR DILATATION 9 0.0176
25 GRANULOCYTE COUNT DECREASED 31 0.0167
26 MYCOBACTERIUM CHELONAE INFECTION 12 0.0162
27 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 20 0.0161
28 ARTERITIS 10 0.0158
29 PLASMA CELL MYELOMA REFRACTORY 20 0.0149
30 AORTITIS 10 0.0146
31 HYPOALBUMINAEMIA 109 0.0140
32 ENDOPHTHALMITIS 79 0.0132
33 BLOOD FIBRINOGEN DECREASED 15 0.0131
34 MYELOSUPPRESSION 460 0.0128
35 FEBRILE INFECTION 15 0.0127
36 SYSTEMIC CANDIDA 32 0.0127
37 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 12 0.0127
38 HYPERURICAEMIA 50 0.0122
39 CELLULITIS ORBITAL 7 0.0120
40 COMPUTERISED TOMOGRAM THORAX ABNORMAL 8 0.0116
41 SECONDARY IMMUNODEFICIENCY 14 0.0115
42 CUSHING'S SYNDROME 8 0.0115
43 STEROID DIABETES 17 0.0113
44 NEUTROPHIL COUNT DECREASED 458 0.0112
45 ARTERIOVENOUS MALFORMATION 10 0.0110
46 DEEP VEIN THROMBOSIS POSTOPERATIVE 22 0.0110
47 KERATOPATHY 17 0.0107
48 JC VIRUS INFECTION 17 0.0106
49 MONOCLONAL IMMUNOGLOBULIN PRESENT 8 0.0105
50 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28 0.0105
51 CENTRAL NERVOUS SYSTEM INFECTION 12 0.0105
52 CENTRAL SEROUS CHORIORETINOPATHY 7 0.0102
53 BILIARY TRACT INFECTION 6 0.0096
54 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 8 0.0095
55 MYELOPATHY 18 0.0095
56 PSEUDOMONAL SEPSIS 16 0.0091
57 MALIGNANT ASCITES 7 0.0091
58 FULMINANT TYPE 1 DIABETES MELLITUS 9 0.0087
59 LYMPHOCYTE COUNT DECREASED 152 0.0086
60 CEREBRAL TOXOPLASMOSIS 8 0.0086
61 SWOLLEN JOINT COUNT INCREASED 27 0.0085
62 PERIODONTITIS 18 0.0083
63 LYMPHADENITIS 20 0.0083
64 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 21 0.0081
65 NEOPLASM RECURRENCE 27 0.0080
66 DISSEMINATED CRYPTOCOCCOSIS 6 0.0079
67 COAGULATION TEST ABNORMAL 6 0.0078
68 KLEBSIELLA INFECTION 38 0.0075
69 DISLOCATION OF VERTEBRA 17 0.0074
70 PROTEIN TOTAL DECREASED 28 0.0074
71 STRONGYLOIDIASIS 12 0.0074
72 DUODENAL ULCER PERFORATION 55 0.0074
73 FACET JOINT SYNDROME 24 0.0074
74 LUPUS VULGARIS 9 0.0071
75 DUODENAL PERFORATION 7 0.0071
76 HYPOFIBRINOGENAEMIA 7 0.0071
77 OSTEOLYSIS 14 0.0068
78 METASTASES TO SPINE 23 0.0068
79 LYMPHANGIOSIS CARCINOMATOSA 7 0.0067
80 TUMOUR LYSIS SYNDROME 59 0.0067
81 LIVER ABSCESS 21 0.0065
82 SMALL INTESTINAL PERFORATION 12 0.0064
83 HYPERPYREXIA 27 0.0064
84 HYPOCALCAEMIA 119 0.0063
85 MYOCARDIAL INJURY 7 0.0062
86 FIBRIN D DIMER INCREASED 22 0.0062
87 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 40 0.0062
88 CYTOMEGALOVIRUS CHORIORETINITIS 12 0.0061
89 INTRAOCULAR PRESSURE INCREASED 78 0.0061
90 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 36 0.0061
91 ANORECTAL DISORDER 12 0.0060
92 ASPERGILLUS INFECTION 39 0.0059
93 MALIGNANT PLEURAL EFFUSION 10 0.0059
94 PNEUMOCYSTIS JIROVECII INFECTION 7 0.0059
95 UPPER RESPIRATORY TRACT INFLAMMATION 7 0.0058
96 PNEUMOCYSTIS JIROVECI PNEUMONIA 13 0.0058
97 RHEUMATIC FEVER 26 0.0058
98 JOINT DESTRUCTION 9 0.0058
99 CYTOKINE RELEASE SYNDROME 116 0.0058
100 ALOPECIA AREATA 10 0.0057
101 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0057
102 HYPOPHOSPHATAEMIA 42 0.0057
103 SCLERITIS 9 0.0056
104 FEBRILE NEUTROPENIA 369 0.0056
105 PLASMA CELL MYELOMA 216 0.0055
106 IMMUNE-MEDIATED LUNG DISEASE 10 0.0055
107 HICCUPS 45 0.0055
108 DISSEMINATED INTRAVASCULAR COAGULATION 77 0.0055
109 HYPOKALAEMIA 252 0.0055
110 BONE MARROW FAILURE 110 0.0054
111 UVEITIS 73 0.0054
112 ENTEROBACTER INFECTION 9 0.0054
113 NEUTROPENIC COLITIS 11 0.0053
114 EXTRADURAL HAEMATOMA 7 0.0053
115 INFECTIOUS PLEURAL EFFUSION 8 0.0053
116 PARAINFLUENZAE VIRUS INFECTION 8 0.0053
117 LYMPHOCYTE PERCENTAGE DECREASED 7 0.0052
118 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
119 MIGRAINE WITH AURA 14 0.0051
120 BRAIN ABSCESS 13 0.0051
121 CORNEAL OPACITY 7 0.0051
122 IMMUNE-MEDIATED HEPATIC DISORDER 10 0.0051
123 CANCER PAIN 13 0.0051
124 GASTROINTESTINAL PERFORATION 21 0.0050
125 CYTOMEGALOVIRUS TEST POSITIVE 9 0.0050
126 PARONYCHIA 22 0.0050
127 PSYCHOLOGICAL TRAUMA 43 0.0050
128 PLASMA CELL MYELOMA RECURRENT 16 0.0049
129 BACTERIAL SEPSIS 16 0.0049
130 LYMPHOCYTE COUNT INCREASED 16 0.0049
131 AMYLASE INCREASED 18 0.0049
132 LEUKOENCEPHALOPATHY 18 0.0048
133 HYDROCEPHALUS 26 0.0048
134 DERMATITIS ACNEIFORM 29 0.0048
135 NEUROLOGICAL DECOMPENSATION 11 0.0047
136 BLOOD LACTATE DEHYDROGENASE INCREASED 74 0.0047
137 PERIPHERAL SENSORY NEUROPATHY 27 0.0046
138 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 33 0.0046
139 COVID-19 PNEUMONIA 54 0.0046
140 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 10 0.0045
141 CYTOMEGALOVIRUS INFECTION REACTIVATION 20 0.0045
142 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
143 HEPATIC FUNCTION ABNORMAL 168 0.0045
144 X-RAY ABNORMAL 8 0.0045
145 MUSCLE INJURY 37 0.0045
146 LARYNGOSPASM 12 0.0045
147 FUNGAEMIA 7 0.0044
148 HYPERTRIGLYCERIDAEMIA 26 0.0044
149 PNEUMOCYSTIS JIROVECII PNEUMONIA 44 0.0044
150 PLEURITIC PAIN 12 0.0043
151 INTERSTITIAL LUNG DISEASE 210 0.0043
152 CYTOPENIA 53 0.0043
153 PLASMACYTOMA 8 0.0043
154 PLATELET COUNT DECREASED 457 0.0043
155 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
156 HYPOGAMMAGLOBULINAEMIA 28 0.0043
157 THROMBOTIC THROMBOCYTOPENIC PURPURA 15 0.0043
158 WHITE BLOOD CELL COUNT DECREASED 460 0.0042
159 ANAPHYLACTIC SHOCK 109 0.0042
160 IGA NEPHROPATHY 7 0.0042
161 HYPERNATRAEMIA 21 0.0042
162 PNEUMATOSIS INTESTINALIS 12 0.0042
163 HYPERPHOSPHATAEMIA 9 0.0042
164 BK VIRUS INFECTION 14 0.0041
165 FOLLICULITIS 43 0.0041
166 CUSHINGOID 13 0.0040
167 DERMATITIS EXFOLIATIVE GENERALISED 14 0.0040
168 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 9 0.0040
169 VITREOUS HAEMORRHAGE 11 0.0040
170 NEOPLASM PROGRESSION 137 0.0039
171 ANGLE CLOSURE GLAUCOMA 10 0.0039
172 IMMUNE-MEDIATED HEPATITIS 8 0.0039
173 HELICOBACTER INFECTION 40 0.0039
174 QUADRIPLEGIA 8 0.0039
175 HYPOMAGNESAEMIA 54 0.0039
176 BLOOD CHLORIDE DECREASED 10 0.0039
177 ADRENAL INSUFFICIENCY 47 0.0039
178 SPINAL CORD COMPRESSION 15 0.0038
179 VENOOCCLUSIVE LIVER DISEASE 19 0.0038
180 ESSENTIAL HYPERTENSION 7 0.0038
181 PULMONARY TOXICITY 27 0.0038
182 ENTEROCOLITIS 22 0.0038
183 PHARYNGEAL ERYTHEMA 8 0.0038
184 PEMPHIGUS 47 0.0038
185 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 28 0.0037
186 IMMUNE THROMBOCYTOPENIA 17 0.0037
187 CRYPTOCOCCOSIS 6 0.0037
188 HIV INFECTION 11 0.0036
189 CONJUNCTIVAL HYPERAEMIA 13 0.0036
190 EMBOLISM VENOUS 11 0.0036
191 PNEUMONIA CYTOMEGALOVIRAL 7 0.0036
192 PNEUMONIA BACTERIAL 33 0.0036
193 ADRENOCORTICAL INSUFFICIENCY ACUTE 7 0.0036
194 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 34 0.0036
195 PNEUMONIA FUNGAL 14 0.0035
196 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
197 SUSPECTED OFF LABEL USE 16 0.0035
198 BLOOD ALBUMIN DECREASED 28 0.0035
199 CYSTITIS HAEMORRHAGIC 14 0.0035
200 PERFORMANCE STATUS DECREASED 16 0.0034
201 VENTRICULAR HYPOKINESIA 11 0.0034
202 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 8 0.0034
203 DIVERTICULAR PERFORATION 7 0.0034
204 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 28 0.0034
205 VENOUS THROMBOSIS LIMB 7 0.0034
206 BLOOD POTASSIUM ABNORMAL 9 0.0034
207 ILEUS PARALYTIC 15 0.0034
208 DEAFNESS NEUROSENSORY 11 0.0033
209 WOUND INFECTION 36 0.0033
210 ASPARTATE AMINOTRANSFERASE INCREASED 174 0.0033
211 CEREBRAL HAEMATOMA 11 0.0033
212 INFUSION RELATED REACTION 215 0.0032
213 DYSENTERY 6 0.0032
214 MULTIPLE MYELOMA 15 0.0032
215 ALANINE AMINOTRANSFERASE INCREASED 196 0.0032
216 MADAROSIS 37 0.0032
217 GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0032
218 METASTASES TO PERITONEUM 8 0.0032
219 HAIR DISORDER 26 0.0032
220 PATHOLOGICAL FRACTURE 16 0.0031
221 TONGUE OEDEMA 12 0.0031
222 SECOND PRIMARY MALIGNANCY 26 0.0031
223 DUODENAL ULCER 22 0.0031
224 GAMMA-GLUTAMYLTRANSFERASE INCREASED 69 0.0031
225 HAEMOLYSIS 24 0.0031
226 ESCHERICHIA SEPSIS 9 0.0031
227 LIVER INJURY 76 0.0031
228 METASTASES TO MENINGES 7 0.0031
229 STOMATITIS 186 0.0031
230 HAIR TEXTURE ABNORMAL 41 0.0031
231 OLIGURIA 19 0.0031
232 FEBRILE BONE MARROW APLASIA 13 0.0031
233 VENOUS THROMBOSIS 12 0.0031
234 HAIR COLOUR CHANGES 38 0.0031
235 HAND DEFORMITY 40 0.0030
236 LUNG OPACITY 8 0.0030
237 SERUM FERRITIN INCREASED 16 0.0030
238 OESOPHAGEAL CANDIDIASIS 12 0.0030
239 BILIRUBIN CONJUGATED INCREASED 7 0.0030
240 LIVE BIRTH 25 0.0030
241 HYPERCAPNIA 9 0.0030
242 METASTASES TO LYMPH NODES 20 0.0030
243 SUPRAVENTRICULAR EXTRASYSTOLES 10 0.0030
244 BACTERAEMIA 35 0.0029
245 NORMAL NEWBORN 16 0.0029
246 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83 0.0029
247 SEPTIC SHOCK 127 0.0029
248 ILEUS 36 0.0029
249 PERICARDITIS 48 0.0029
250 C-REACTIVE PROTEIN INCREASED 103 0.0028
251 NEUTROPHIL COUNT ABNORMAL 8 0.0028
252 ACUTE LYMPHOCYTIC LEUKAEMIA 8 0.0028
253 STEM CELL TRANSPLANT 7 0.0028
254 NEUTROPENIC SEPSIS 20 0.0028
255 OSTEITIS 7 0.0028
256 SYNOVITIS 50 0.0028
257 LEUKOPENIA 138 0.0028
258 NEUTROPENIA 375 0.0028
259 HAEMODYNAMIC INSTABILITY 21 0.0028
260 NEUROTOXICITY 48 0.0027
261 CORNEAL DISORDER 6 0.0027
262 BLOOD PHOSPHORUS DECREASED 10 0.0027
263 HYPERGLYCAEMIA 99 0.0027
264 PERIPHERAL VENOUS DISEASE 11 0.0027
265 BACTERIAL TEST POSITIVE 6 0.0027
266 ENTEROCOCCAL INFECTION 13 0.0027
267 GUILLAIN-BARRE SYNDROME 13 0.0027
268 LEFT VENTRICULAR DYSFUNCTION 18 0.0027
269 THROMBOCYTOPENIA 299 0.0027
270 ANAPHYLACTOID REACTION 11 0.0027
271 ANAEMIA 508 0.0027
272 LUNG ADENOCARCINOMA 8 0.0027
273 C-REACTIVE PROTEIN ABNORMAL 17 0.0026
274 DRUG-INDUCED LIVER INJURY 83 0.0026
275 BLOOD UREA INCREASED 44 0.0026
276 HYPERAMMONAEMIA 13 0.0026
277 DIFFUSE LARGE B-CELL LYMPHOMA 20 0.0026
278 HYPERCHOLESTEROLAEMIA 25 0.0026
279 NEUROPATHY PERIPHERAL 246 0.0026
280 JAUNDICE CHOLESTATIC 9 0.0025
281 AGRANULOCYTOSIS 47 0.0025
282 HEPATITIS B REACTIVATION 8 0.0025
283 SKIN NECROSIS 13 0.0025
284 AZOTAEMIA 10 0.0025
285 TACHYPNOEA 34 0.0025
286 BLOOD ALKALINE PHOSPHATASE INCREASED 62 0.0025
287 DRUG ERUPTION 44 0.0025
288 MONOCYTE COUNT INCREASED 9 0.0025
289 BURSITIS 30 0.0025
290 GRANULOCYTOPENIA 14 0.0025
291 TUMOUR HAEMORRHAGE 7 0.0025
292 LARGE INTESTINE PERFORATION 17 0.0024
293 IMMUNE-MEDIATED ENTEROCOLITIS 9 0.0024
294 NEUTROPHIL COUNT INCREASED 25 0.0024
295 LIP PAIN 7 0.0024
296 RHEUMATOID FACTOR POSITIVE 14 0.0024
297 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
298 ELECTROLYTE IMBALANCE 28 0.0024
299 PRODUCT LABEL CONFUSION 14 0.0024
300 BLEPHAROSPASM 15 0.0024
301 AUTOIMMUNE DISORDER 23 0.0024
302 HEPATITIS FULMINANT 7 0.0024
303 B-CELL LYMPHOMA 8 0.0024
304 GASTRIC INFECTION 9 0.0024
305 VISUAL ACUITY REDUCED 78 0.0023
306 ENTERITIS 15 0.0023
307 TEMPERATURE INTOLERANCE 24 0.0023
308 RHINOVIRUS INFECTION 9 0.0023
309 JOINT RANGE OF MOTION DECREASED 31 0.0023
310 CANDIDA INFECTION 39 0.0023
311 ORAL INFECTION 9 0.0023
312 PULMONARY HAEMORRHAGE 18 0.0023
313 BLOOD BILIRUBIN INCREASED 62 0.0023
314 CYTOMEGALOVIRUS INFECTION 38 0.0023
315 BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0023
316 CHOLANGITIS 14 0.0023
317 SINUS TACHYCARDIA 32 0.0023
318 METASTASES TO CENTRAL NERVOUS SYSTEM 29 0.0022
319 PNEUMONITIS 61 0.0022
320 COMPRESSION FRACTURE 12 0.0022
321 SKIN WARM 13 0.0022
322 ACIDOSIS 17 0.0022
323 PRESCRIBED OVERDOSE 43 0.0022
324 BONE LESION 8 0.0022
325 IRIDOCYCLITIS 7 0.0022
326 PROTEIN URINE PRESENT 11 0.0022
327 HYPERCALCAEMIA 27 0.0022
328 PANCYTOPENIA 122 0.0022
329 DRUG TOLERANCE 11 0.0022
330 ATELECTASIS 21 0.0022
331 POLYNEUROPATHY 26 0.0022
332 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
333 PSYCHIATRIC SYMPTOM 16 0.0022
334 HYPONATRAEMIA 122 0.0022
335 GASTRIC ULCER HAEMORRHAGE 12 0.0022
336 METASTASES TO LIVER 38 0.0022
337 HYPERTRANSAMINASAEMIA 15 0.0022
338 LOWER RESPIRATORY TRACT INFECTION 98 0.0022
339 IMMUNOSUPPRESSION 19 0.0022
340 IRRITABLE BOWEL SYNDROME 46 0.0021
341 PULMONARY ALVEOLAR HAEMORRHAGE 12 0.0021
342 DRUG TOLERANCE DECREASED 6 0.0021
343 CARDIOTOXICITY 19 0.0021
344 ORAL CANDIDIASIS 28 0.0021
345 CARDIAC TAMPONADE 10 0.0021
346 MUCOSAL INFLAMMATION 55 0.0021
347 GRAFT VERSUS HOST DISEASE 15 0.0021
348 WHITE BLOOD CELL COUNT INCREASED 80 0.0021
349 WOUND 58 0.0021
350 STRESS CARDIOMYOPATHY 12 0.0021
351 URINE OUTPUT DECREASED 18 0.0021
352 MALNUTRITION 23 0.0021
353 ASCITES 60 0.0020
354 ERYTHEMA MULTIFORME 19 0.0020
355 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
356 BREATH SOUNDS ABNORMAL 10 0.0020
357 HYPERVOLAEMIA 10 0.0020
358 HAEMOGLOBIN ABNORMAL 13 0.0020
359 HAEMATOTOXICITY 19 0.0020
360 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
361 DISEASE PROGRESSION 234 0.0020
362 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
363 PRODUCT CONTAMINATION 7 0.0020
364 RECURRENT CANCER 8 0.0020
365 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 20 0.0019
366 EXTRAVASATION 8 0.0019
367 BRAIN DEATH 6 0.0019
368 HEPATOMEGALY 19 0.0019
369 EYE PAIN 108 0.0019
370 GASTROINTESTINAL INFECTION 17 0.0019
371 PNEUMOTHORAX 30 0.0019
372 DELIRIUM 65 0.0019
373 MALIGNANT NEOPLASM PROGRESSION 191 0.0019
374 COAGULOPATHY 31 0.0019
375 THERAPY PARTIAL RESPONDER 29 0.0019
376 ANAL ABSCESS 10 0.0019
377 MOUTH ULCERATION 39 0.0018
378 SEPSIS 204 0.0018
379 NAIL DISORDER 16 0.0018
380 RESPIRATORY FAILURE 133 0.0018
381 PLEURAL EFFUSION 110 0.0018
382 PRESCRIBED UNDERDOSE 36 0.0018
383 HEPATIC CYTOLYSIS 23 0.0018
384 CARDIAC FAILURE ACUTE 12 0.0018
385 IMPAIRED HEALING 59 0.0018
386 MENINGITIS 12 0.0018
387 PYREXIA 620 0.0018
388 GLOSSODYNIA 40 0.0018
389 LARYNGEAL OEDEMA 11 0.0018
390 ANGIOPATHY 10 0.0018
391 DYSPHORIA 9 0.0018
392 THERAPEUTIC PRODUCT EFFECT DECREASED 79 0.0018
393 PHLEBITIS 9 0.0018
394 NASAL DRYNESS 11 0.0018
395 DEVICE RELATED INFECTION 27 0.0018
396 OEDEMA 95 0.0017
397 CACHEXIA 9 0.0017
398 IMPAIRED QUALITY OF LIFE 25 0.0017
399 HYDRONEPHROSIS 13 0.0017
400 MULTI-ORGAN FAILURE 30 0.0017
401 NERVE COMPRESSION 16 0.0017
402 FACE OEDEMA 29 0.0017
403 CEREBRAL INFARCTION 42 0.0017
404 LIVER DISORDER 76 0.0017
405 APPENDICITIS 16 0.0017
406 POLYARTHRITIS 9 0.0017
407 TREATMENT FAILURE 141 0.0017
408 HEPATIC FAILURE 51 0.0017
409 CHOLECYSTITIS 20 0.0017
410 NON-SMALL CELL LUNG CANCER 8 0.0017
411 HEPATITIS B 10 0.0017
412 PLATELET COUNT ABNORMAL 10 0.0017
413 BLOOD CREATININE INCREASED 108 0.0017
414 CYANOSIS 26 0.0017
415 ABSCESS LIMB 7 0.0016
416 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 90 0.0016
417 ACUTE RESPIRATORY DISTRESS SYNDROME 29 0.0016
418 LUNG NEOPLASM 7 0.0016
419 STAPHYLOCOCCAL SEPSIS 8 0.0016
420 ORGANISING PNEUMONIA 8 0.0016
421 CHAPPED LIPS 7 0.0016
422 CARDIAC DYSFUNCTION 6 0.0016
423 BACTERIAL INFECTION 30 0.0016
424 MACULAR OEDEMA 9 0.0016
425 LEUKOCYTOSIS 29 0.0016
426 CHRONIC SINUSITIS 6 0.0016
427 ASPHYXIA 13 0.0016
428 MELAENA 35 0.0016
429 DECREASED APPETITE 367 0.0016
430 OBESITY 25 0.0016
431 LIPASE INCREASED 12 0.0016
432 HAEMOLYTIC ANAEMIA 14 0.0016
433 LYMPHOPENIA 22 0.0016
434 CONGENITAL ANOMALY 12 0.0015
435 VENTRICULAR EXTRASYSTOLES 16 0.0015
436 ACUTE MYELOID LEUKAEMIA 24 0.0015
437 THROMBOTIC MICROANGIOPATHY 15 0.0015
438 HERPES SIMPLEX 10 0.0015
439 CONTRAINDICATED PRODUCT ADMINISTERED 46 0.0015
440 PLEURISY 9 0.0015
441 ARTHRITIS INFECTIVE 7 0.0015
442 HAEMOPTYSIS 42 0.0015
443 SWOLLEN TONGUE 47 0.0015
444 ATRIAL FLUTTER 12 0.0015
445 ORAL DISORDER 11 0.0015
446 UPPER RESPIRATORY TRACT INFECTION 69 0.0015
447 BREAST CANCER METASTATIC 16 0.0015
448 GINGIVITIS 8 0.0015
449 COLITIS ISCHAEMIC 10 0.0015
450 SHOCK 34 0.0015
451 OXYGEN SATURATION DECREASED 83 0.0015
452 CARDIAC FAILURE 118 0.0015
453 ARTHRITIS BACTERIAL 6 0.0015
454 OSTEONECROSIS 48 0.0015
455 FAECALOMA 8 0.0015
456 VASCULITIS 17 0.0015
457 PRODUCT USE IN UNAPPROVED INDICATION 361 0.0015
458 HEPATIC ENZYME INCREASED 99 0.0015
459 SPLENOMEGALY 17 0.0014
460 CHOKING SENSATION 8 0.0014
461 SINUS BRADYCARDIA 14 0.0014
462 HYPERBILIRUBINAEMIA 15 0.0014
463 ENCEPHALITIS 10 0.0014
464 EMBOLISM 12 0.0014
465 GASTROENTERITIS 21 0.0014
466 SYSTEMIC LUPUS ERYTHEMATOSUS 51 0.0014
467 PALLOR 39 0.0014
468 HYPERLIPIDAEMIA 17 0.0014
469 PAPULE 10 0.0014
470 RETINAL DETACHMENT 13 0.0014
471 GENERALISED ERYTHEMA 8 0.0014
472 PNEUMONIA ASPIRATION 35 0.0014
473 MYOPATHY 12 0.0014
474 OSTEONECROSIS OF JAW 34 0.0014
475 HYPOXIA 48 0.0014
476 CORONAVIRUS INFECTION 9 0.0014
477 APPETITE DISORDER 9 0.0014
478 RENAL IMPAIRMENT 114 0.0014
479 DERMATITIS ALLERGIC 17 0.0014
480 SHOCK HAEMORRHAGIC 11 0.0013
481 BRAIN OEDEMA 17 0.0013
482 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
483 EPILEPSY 41 0.0013
484 DERMATITIS 28 0.0013
485 OSTEOMYELITIS 24 0.0013
486 SUDDEN DEATH 14 0.0013
487 HAEMOGLOBIN DECREASED 135 0.0013
488 ECCHYMOSIS 9 0.0013
489 ANGIOEDEMA 58 0.0013
490 BOWEL MOVEMENT IRREGULARITY 10 0.0013
491 ENCEPHALOPATHY 32 0.0013
492 IRON DEFICIENCY ANAEMIA 12 0.0013
493 DEEP VEIN THROMBOSIS 84 0.0013
494 PRODUCT PRESCRIBING ISSUE 28 0.0013
495 PSEUDOMONAS INFECTION 11 0.0013
496 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
497 GENERAL PHYSICAL HEALTH DETERIORATION 148 0.0013
498 PULMONARY MASS 19 0.0013
499 INTESTINAL ISCHAEMIA 7 0.0013
500 TOOTHACHE 23 0.0013
501 CHEST DISCOMFORT 129 0.0013
502 RASH MACULO-PAPULAR 28 0.0013
503 STREPTOCOCCAL INFECTION 7 0.0013
504 ACUTE RESPIRATORY FAILURE 24 0.0012
505 MYELODYSPLASTIC SYNDROME 18 0.0012
506 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 29 0.0012
507 RHINITIS 10 0.0012
508 RESPIRATORY RATE INCREASED 11 0.0012
509 SKIN TOXICITY 7 0.0012
510 BREAST CANCER STAGE III 8 0.0012
511 PNEUMONIA 399 0.0012
512 TASTE DISORDER 25 0.0012
513 ANAPHYLACTIC REACTION 68 0.0012
514 MOUTH HAEMORRHAGE 9 0.0012
515 HYPERKALAEMIA 43 0.0012
516 MYOSITIS 11 0.0012
517 INTENTIONAL PRODUCT USE ISSUE 107 0.0012
518 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0012
519 GENERALISED OEDEMA 15 0.0012
520 GASTRIC ULCER 23 0.0012
521 DISCOMFORT 73 0.0012
522 FULL BLOOD COUNT DECREASED 24 0.0012
523 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
524 ULCER HAEMORRHAGE 8 0.0012
525 PULMONARY EMBOLISM 112 0.0012
526 VENTRICULAR FIBRILLATION 13 0.0012
527 STEVENS-JOHNSON SYNDROME 26 0.0012
528 TRANSAMINASES INCREASED 26 0.0012
529 DYSPHONIA 68 0.0012
530 CONSTIPATION 253 0.0012
531 BLOOD PRESSURE DECREASED 77 0.0012
532 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
533 METASTASES TO BONE 19 0.0012
534 THERAPY NON-RESPONDER 52 0.0012
535 AUTOIMMUNE HEPATITIS 8 0.0011
536 MITRAL VALVE INCOMPETENCE 13 0.0011
537 INFECTION 166 0.0011
538 IMMUNODEFICIENCY 17 0.0011
539 MYOCARDITIS 13 0.0011
540 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
541 TRICUSPID VALVE INCOMPETENCE 9 0.0011
542 PURPURA 10 0.0011
543 METASTASES TO LUNG 13 0.0011
544 ISCHAEMIC STROKE 20 0.0011
545 RED BLOOD CELL COUNT DECREASED 32 0.0011
546 BLOOD SODIUM DECREASED 21 0.0011
547 DRUG INTOLERANCE 107 0.0011
548 OFF LABEL USE 967 0.0011
549 ALOPECIA 216 0.0011
550 ACUTE HEPATIC FAILURE 15 0.0011
551 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
552 PROCTALGIA 7 0.0011
553 BLISTER 61 0.0011
554 UROSEPSIS 10 0.0011
555 TOOTH ABSCESS 11 0.0011
556 SUBARACHNOID HAEMORRHAGE 11 0.0011
557 CARDIO-RESPIRATORY ARREST 45 0.0011
558 PANCREATITIS ACUTE 24 0.0011
559 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
560 CHOLECYSTITIS ACUTE 6 0.0011
561 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
562 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
563 PROTEINURIA 20 0.0011
564 CHILLS 123 0.0010
565 PHARYNGITIS 13 0.0010
566 PARALYSIS 15 0.0010
567 BLOOD POTASSIUM INCREASED 17 0.0010
568 CARDIOGENIC SHOCK 15 0.0010
569 SWELLING FACE 68 0.0010
570 HERPES ZOSTER 60 0.0010
571 MENTAL STATUS CHANGES 29 0.0010
572 LOWER LIMB FRACTURE 20 0.0010
573 ACUTE KIDNEY INJURY 159 0.0010
574 MUSCULOSKELETAL CHEST PAIN 16 0.0010
575 BLOOD POTASSIUM DECREASED 31 0.0010
576 HAEMATURIA 35 0.0010
577 VITREOUS FLOATERS 10 0.0010
578 CEREBRAL HAEMORRHAGE 36 0.0010
579 RESPIRATORY DISORDER 30 0.0010
580 TACHYCARDIA 89 0.0010
581 CIRCULATORY COLLAPSE 17 0.0010
582 PLATELET COUNT INCREASED 13 0.0010
583 PULMONARY FIBROSIS 19 0.0010
584 DECUBITUS ULCER 8 0.0010
585 EAR PAIN 19 0.0010
586 ELECTROCARDIOGRAM QT PROLONGED 35 0.0010
587 HYPOTHYROIDISM 31 0.0010
588 LYMPHOMA 15 0.0010
589 PERSONALITY CHANGE 9 0.0010
590 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
591 HEMIPLEGIA 8 0.0010
592 FUNGAL INFECTION 32 0.0010
593 ATRIAL FIBRILLATION 93 0.0010
594 CELLULITIS 48 0.0010
595 GINGIVAL BLEEDING 13 0.0010
596 PERICARDIAL EFFUSION 22 0.0010
597 ACUTE MYOCARDIAL INFARCTION 28 0.0009
598 SENSATION OF FOREIGN BODY 8 0.0009
599 SCIATICA 15 0.0009
600 COLON CANCER 14 0.0009
601 SLEEP DISORDER 66 0.0009
602 MATERNAL EXPOSURE DURING PREGNANCY 83 0.0009
603 ANURIA 8 0.0009
604 PYELONEPHRITIS 8 0.0009
605 HAEMORRHOIDS 18 0.0009
606 PRODUCTIVE COUGH 44 0.0009
607 PERITONITIS 19 0.0009
608 HYPERTHERMIA 7 0.0009
609 CONJUNCTIVITIS 17 0.0009
610 GASTRITIS 24 0.0009
611 GROIN PAIN 8 0.0009
612 RENAL FAILURE CHRONIC 7 0.0009
613 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
614 NERVOUS SYSTEM DISORDER 28 0.0009
615 INTESTINAL PERFORATION 10 0.0009
616 BRONCHIECTASIS 6 0.0009
617 BLOOD CALCIUM DECREASED 10 0.0009
618 SWELLING 83 0.0009
619 REBOUND EFFECT 10 0.0009
620 VOMITING 416 0.0009
621 BODY TEMPERATURE INCREASED 18 0.0009
622 CARDIOMYOPATHY 13 0.0009
623 BONE DISORDER 16 0.0009
624 INITIAL INSOMNIA 9 0.0009
625 COLITIS 33 0.0009
626 SENSORY LOSS 7 0.0009
627 MUSCLE ATROPHY 11 0.0009
628 ARRHYTHMIA 41 0.0009
629 HYPOAESTHESIA 129 0.0009
630 OEDEMA PERIPHERAL 105 0.0009
631 HEPATITIS 22 0.0009
632 HAEMATOCRIT DECREASED 17 0.0009
633 POLYURIA 7 0.0009
634 ANOREXIA 11 0.0009
635 SKIN ULCER 22 0.0009
636 ESCHERICHIA INFECTION 7 0.0009
637 PULMONARY OEDEMA 38 0.0008
638 BRADYCARDIA 45 0.0008
639 VENTRICULAR TACHYCARDIA 14 0.0008
640 LYMPHADENOPATHY 30 0.0008
641 SPINAL COMPRESSION FRACTURE 7 0.0008
642 ACUTE CORONARY SYNDROME 7 0.0008
643 LUNG INFECTION 13 0.0008
644 HAEMODIALYSIS 7 0.0008
645 GLAUCOMA 16 0.0008
646 ARTHROPATHY 46 0.0008
647 GASTROINTESTINAL DISORDER 74 0.0008
648 RENAL FAILURE ACUTE 35 0.0008
649 HYPOPHAGIA 21 0.0008
650 BONE PAIN 48 0.0008
651 STAPHYLOCOCCAL INFECTION 27 0.0008
652 ERYTHEMA 168 0.0008
653 CYSTITIS 26 0.0008
654 CONDITION AGGRAVATED 248 0.0008
655 INFLAMMATION 42 0.0008
656 CARDIAC ARREST 67 0.0008
657 BLOOD MAGNESIUM DECREASED 7 0.0008
658 DEHYDRATION 108 0.0008
659 RESPIRATORY TRACT INFECTION 21 0.0008
660 SKIN INFECTION 9 0.0008
661 TYPE 2 DIABETES MELLITUS 27 0.0008
662 OCULAR DISCOMFORT 9 0.0008
663 HYPOTONIA 8 0.0008
664 PERIPHERAL COLDNESS 11 0.0008
665 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
666 RESPIRATORY ARREST 22 0.0008
667 PHOTOPHOBIA 15 0.0008
668 SPINAL OSTEOARTHRITIS 7 0.0008
669 GRIP STRENGTH DECREASED 7 0.0008
670 ABDOMINAL PAIN 185 0.0008
671 PRODUCT USE ISSUE 149 0.0008
672 MANIA 13 0.0008
673 FEEDING DISORDER 16 0.0008
674 HYPERSENSITIVITY 146 0.0008
675 DRUG LEVEL INCREASED 13 0.0008
676 NAUSEA 620 0.0008
677 SKIN DISORDER 26 0.0008
678 HYPERTENSION 165 0.0008
679 NIGHT SWEATS 25 0.0008
680 HYPOGLYCAEMIA 37 0.0008
681 PALPITATIONS 89 0.0008
682 RASH 331 0.0008
683 THROMBOSIS 61 0.0008
684 ILL-DEFINED DISORDER 46 0.0008
685 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
686 OSTEOARTHRITIS 32 0.0008
687 RASH ERYTHEMATOUS 36 0.0008
688 MUSCLE RIGIDITY 9 0.0008
689 RENAL FAILURE 99 0.0007
690 ARTERIOSCLEROSIS 7 0.0007
691 DIARRHOEA 479 0.0007
692 DECREASED ACTIVITY 8 0.0007
693 COLD SWEAT 13 0.0007
694 CARDIOMEGALY 9 0.0007
695 ABDOMINAL DISTENSION 76 0.0007
696 WHEEZING 43 0.0007
697 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
698 MUSCULAR WEAKNESS 82 0.0007
699 FEELING COLD 20 0.0007
700 ORAL HERPES 14 0.0007
701 LUNG DISORDER 35 0.0007
702 INJURY 50 0.0007
703 SEIZURE 82 0.0007
704 STATUS EPILEPTICUS 8 0.0007
705 EJECTION FRACTION DECREASED 11 0.0007
706 DYSPNOEA 400 0.0007
707 CONTUSION 68 0.0007
708 PAIN IN JAW 20 0.0007
709 MEDICATION ERROR 39 0.0007
710 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
711 GASTRIC HAEMORRHAGE 8 0.0007
712 GASTROINTESTINAL HAEMORRHAGE 58 0.0007
713 EMPHYSEMA 7 0.0007
714 FAECES DISCOLOURED 15 0.0007
715 HYPOTHERMIA 7 0.0007
716 INTESTINAL OBSTRUCTION 26 0.0007
717 EYELID OEDEMA 8 0.0007
718 LOSS OF CONSCIOUSNESS 87 0.0007
719 COVID-19 119 0.0007
720 CHOLESTASIS 13 0.0007
721 ATAXIA 8 0.0007
722 PETECHIAE 7 0.0007
723 HAEMATEMESIS 17 0.0007
724 ORAL PAIN 15 0.0007
725 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0007
726 BRAIN NEOPLASM 6 0.0007
727 LIVER FUNCTION TEST INCREASED 14 0.0007
728 DYSURIA 24 0.0007
729 HEMIPARESIS 11 0.0006
730 PREGNANCY 13 0.0006
731 HYPOTENSION 130 0.0006
732 HEPATIC STEATOSIS 12 0.0006
733 SINUSITIS 66 0.0006
734 MASS 9 0.0006
735 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
736 ASPIRATION 7 0.0006
737 ASTHENIA 239 0.0006
738 INSOMNIA 169 0.0006
739 DENTAL CARIES 7 0.0006
740 BRONCHOSPASM 9 0.0006
741 CORONARY ARTERY DISEASE 19 0.0006
742 NEPHROPATHY TOXIC 7 0.0006
743 ABDOMINAL DISCOMFORT 104 0.0006
744 DYSPEPSIA 61 0.0006
745 CONFUSIONAL STATE 100 0.0006
746 SKIN FISSURES 12 0.0006
747 COUGH 171 0.0006
748 PULMONARY CONGESTION 8 0.0006
749 POOR QUALITY SLEEP 13 0.0006
750 VIRAL INFECTION 20 0.0006
751 DYSPHAGIA 57 0.0006
752 HYPOAESTHESIA ORAL 9 0.0006
753 EXPOSURE DURING PREGNANCY 37 0.0006
754 PSORIATIC ARTHROPATHY 24 0.0006
755 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
756 NECK PAIN 33 0.0006
757 MYOCLONUS 7 0.0006
758 HAEMATOMA 15 0.0006
759 THERAPEUTIC RESPONSE DECREASED 35 0.0006
760 NOCTURIA 7 0.0006
761 NO THERAPEUTIC RESPONSE 7 0.0006
762 SYNCOPE 57 0.0006
763 URINARY RETENTION 19 0.0006
764 HEART RATE INCREASED 56 0.0006
765 TOOTH EXTRACTION 7 0.0006
766 JAUNDICE 15 0.0006
767 DISORIENTATION 22 0.0006
768 FEELING HOT 34 0.0006
769 PARAESTHESIA 87 0.0006
770 PELVIC PAIN 10 0.0005
771 MALAISE 241 0.0005
772 END STAGE RENAL DISEASE 10 0.0005
773 BACK PAIN 127 0.0005
774 PRURITUS 209 0.0005
775 DIABETIC KETOACIDOSIS 13 0.0005
776 FLUSHING 55 0.0005
777 URINARY TRACT INFECTION 92 0.0005
778 HEPATOTOXICITY 12 0.0005
779 DIABETES MELLITUS 41 0.0005
780 RHEUMATOID ARTHRITIS 61 0.0005
781 BLOOD CHOLESTEROL INCREASED 25 0.0005
782 IMMUNE SYSTEM DISORDER 7 0.0005
783 OROPHARYNGEAL PAIN 49 0.0005
784 ROAD TRAFFIC ACCIDENT 22 0.0005
785 COMA 25 0.0005
786 MIGRAINE 50 0.0005
787 EPISTAXIS 39 0.0005
788 PANCREATIC CARCINOMA 15 0.0005
789 DRY MOUTH 42 0.0005
790 FATIGUE 403 0.0005
791 JOINT SWELLING 62 0.0005
792 DYSGEUSIA 38 0.0005
793 URTICARIA 84 0.0005
794 DEAFNESS 13 0.0005
795 CHEST PAIN 92 0.0005
796 APHASIA 15 0.0005
797 BLINDNESS UNILATERAL 7 0.0005
798 PRODUCT ADMINISTRATION ERROR 10 0.0005
799 SEASONAL ALLERGY 7 0.0005
800 NASOPHARYNGITIS 91 0.0005
801 FIBROMYALGIA 12 0.0005
802 DIALYSIS 7 0.0005
803 BLINDNESS 20 0.0005
804 PERIPHERAL SWELLING 75 0.0005
805 PHOTOSENSITIVITY REACTION 8 0.0005
806 VISUAL IMPAIRMENT 60 0.0005
807 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
808 THROAT TIGHTNESS 13 0.0005
809 RHABDOMYOLYSIS 20 0.0005
810 MUSCULOSKELETAL STIFFNESS 42 0.0005
811 HEPATIC CIRRHOSIS 9 0.0005
812 GAIT INABILITY 16 0.0005
813 MUSCULOSKELETAL PAIN 25 0.0005
814 LABORATORY TEST ABNORMAL 14 0.0005
815 WEIGHT DECREASED 132 0.0005
816 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
817 RESPIRATORY DISTRESS 13 0.0005
818 MOOD SWINGS 15 0.0005
819 WEIGHT INCREASED 105 0.0005
820 HAEMORRHAGE INTRACRANIAL 7 0.0005
821 LACRIMATION INCREASED 14 0.0005
822 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
823 OSTEOPENIA 7 0.0005
824 ASTHMA 52 0.0005
825 LOCAL SWELLING 8 0.0005
826 BLOOD PRESSURE INCREASED 70 0.0005
827 EOSINOPHILIA 8 0.0005
828 DISABILITY 9 0.0005
829 ABDOMINAL PAIN UPPER 93 0.0005
830 DYSPNOEA EXERTIONAL 17 0.0005
831 MENINGIOMA 7 0.0004
832 LIVER FUNCTION TEST ABNORMAL 13 0.0004
833 MOBILITY DECREASED 32 0.0004
834 DRUG INTERACTION 70 0.0004
835 AGEUSIA 11 0.0004
836 PAIN 270 0.0004
837 ABSCESS 7 0.0004
838 SKIN LESION 12 0.0004
839 CONVULSION 25 0.0004
840 SENSORY DISTURBANCE 7 0.0004
841 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
842 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
843 BRONCHITIS 32 0.0004
844 PULMONARY HYPERTENSION 9 0.0004
845 COGNITIVE DISORDER 20 0.0004
846 UNRESPONSIVE TO STIMULI 11 0.0004
847 ARTHRALGIA 176 0.0004
848 ADVERSE EVENT 39 0.0004
849 LOCALISED INFECTION 10 0.0004
850 ERUCTATION 8 0.0004
851 INFLUENZA LIKE ILLNESS 34 0.0004
852 HOT FLUSH 31 0.0004
853 MUSCULOSKELETAL DISCOMFORT 7 0.0004
854 PAIN IN EXTREMITY 119 0.0004
855 HYPERHIDROSIS 52 0.0004
856 CATARACT 24 0.0004
857 OCULAR HYPERAEMIA 19 0.0004
858 DISEASE RECURRENCE 19 0.0004
859 HAEMATOCHEZIA 22 0.0004
860 DIVERTICULITIS 11 0.0004
861 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
862 RASH PRURITIC 21 0.0004
863 DIZZINESS 193 0.0004
864 UNDERDOSE 28 0.0004
865 BRAIN FOG 6 0.0004
866 RESTLESSNESS 14 0.0004
867 VERTIGO 23 0.0004
868 EATING DISORDER 8 0.0004
869 DRUG INEFFECTIVE 490 0.0004
870 MENTAL IMPAIRMENT 9 0.0004
871 URINARY INCONTINENCE 11 0.0004
872 MENTAL DISORDER 16 0.0004
873 MOOD ALTERED 10 0.0004
874 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 66 0.0004
875 PREMATURE BABY 11 0.0004
876 MYALGIA 62 0.0004
877 HEADACHE 228 0.0004
878 DEATH 312 0.0004
879 POLLAKIURIA 15 0.0004
880 PANCREATITIS 19 0.0004
881 RASH PAPULAR 8 0.0004
882 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
883 INFLUENZA 39 0.0003
884 TINNITUS 16 0.0003
885 ANXIETY 99 0.0003
886 DEPRESSION 79 0.0003
887 METABOLIC ACIDOSIS 11 0.0003
888 ECZEMA 18 0.0003
889 MOVEMENT DISORDER 11 0.0003
890 LACTIC ACIDOSIS 11 0.0003
891 PSYCHOTIC DISORDER 10 0.0003
892 EAR INFECTION 9 0.0003
893 FLUID RETENTION 17 0.0003
894 TREMOR 55 0.0003
895 NEOPLASM MALIGNANT 22 0.0003
896 PRESYNCOPE 8 0.0003
897 EYE PRURITUS 11 0.0003
898 RHINORRHOEA 21 0.0003
899 FEMUR FRACTURE 10 0.0003
900 DYSKINESIA 13 0.0003
901 DYSARTHRIA 12 0.0003
902 ABDOMINAL PAIN LOWER 8 0.0003
903 TOOTH DISORDER 7 0.0003
904 FEELING ABNORMAL 75 0.0003
905 THROAT IRRITATION 14 0.0003
906 DRUG RESISTANCE 8 0.0003
907 DIPLOPIA 8 0.0003
908 CHOLELITHIASIS 10 0.0003
909 MUSCLE TWITCHING 7 0.0003
910 RENAL DISORDER 14 0.0003
911 EYE IRRITATION 17 0.0003
912 DRY SKIN 39 0.0003
913 AMNESIA 19 0.0003
914 BLOOD GLUCOSE INCREASED 55 0.0003
915 MUSCLE SPASMS 53 0.0003
916 FALL 96 0.0003
917 PROCEDURAL PAIN 8 0.0003
918 NEURALGIA 7 0.0003
919 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
920 GAIT DISTURBANCE 55 0.0003
921 VISION BLURRED 39 0.0003
922 HYPERSOMNIA 8 0.0003
923 TOXICITY TO VARIOUS AGENTS 47 0.0003
924 ACNE 21 0.0003
925 EYE DISORDER 9 0.0003
926 EMOTIONAL DISTRESS 33 0.0003
927 RASH GENERALISED 7 0.0003
928 LIP SWELLING 9 0.0003
929 HAEMORRHAGE 28 0.0003
930 SPEECH DISORDER 14 0.0003
931 JOINT STIFFNESS 7 0.0003
932 IRRITABILITY 16 0.0003
933 CHROMATURIA 6 0.0003
934 SOMNOLENCE 53 0.0003
935 INJECTION SITE REACTION 18 0.0003
936 HALLUCINATION 19 0.0003
937 HIP FRACTURE 8 0.0002
938 PANIC ATTACK 9 0.0002
939 DEPRESSED MOOD 13 0.0002
940 LUNG NEOPLASM MALIGNANT 10 0.0002
941 PRODUCT QUALITY ISSUE 33 0.0002
942 BURNING SENSATION 17 0.0002
943 EYE SWELLING 9 0.0002
944 ARTHRITIS 19 0.0002
945 NEPHROLITHIASIS 11 0.0002
946 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
947 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
948 RASH MACULAR 8 0.0002
949 HEART RATE DECREASED 8 0.0002
950 EMOTIONAL DISORDER 7 0.0002
951 CARDIAC DISORDER 21 0.0002
952 CARDIAC FAILURE CONGESTIVE 18 0.0002
953 DRY EYE 11 0.0002
954 BALANCE DISORDER 19 0.0002
955 SKIN DISCOLOURATION 10 0.0002
956 ADVERSE DRUG REACTION 19 0.0002
957 PRODUCT DOSE OMISSION ISSUE 62 0.0002
958 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
959 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
960 AGITATION 15 0.0002
961 ABNORMAL BEHAVIOUR 8 0.0002
962 SKIN EXFOLIATION 17 0.0002
963 OVERDOSE 43 0.0002
964 SUICIDAL IDEATION 18 0.0002
965 OSTEOPOROSIS 8 0.0002
966 BREAST CANCER 18 0.0002
967 LETHARGY 11 0.0002
968 RECTAL HAEMORRHAGE 8 0.0002
969 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
970 ILLNESS 18 0.0002
971 UNEVALUABLE EVENT 13 0.0002
972 MEMORY IMPAIRMENT 23 0.0002
973 ACCIDENTAL OVERDOSE 6 0.0002
974 HOSPITALISATION 25 0.0002
975 PSORIASIS 21 0.0002
976 INTENTIONAL PRODUCT MISUSE 14 0.0002
977 FLATULENCE 9 0.0002
978 INJECTION SITE PAIN 47 0.0002
979 NASAL CONGESTION 9 0.0002
980 DERMATITIS ATOPIC 8 0.0002
981 MYOCARDIAL INFARCTION 26 0.0001
982 DISTURBANCE IN ATTENTION 8 0.0001
983 INJECTION SITE ERYTHEMA 18 0.0001
984 INJECTION SITE SWELLING 11 0.0001
985 THERAPY INTERRUPTED 10 0.0001
986 COLITIS ULCERATIVE 6 0.0001
987 COLORECTAL CANCER 6 0.0001
988 CEREBROVASCULAR ACCIDENT 18 0.0001
989 CHRONIC KIDNEY DISEASE 8 0.0001
990 DRUG ABUSE 8 0.0001
991 DEVICE MALFUNCTION 6 0.0001
992 NO ADVERSE EVENT 15 0.0001
993 INCORRECT DOSE ADMINISTERED 18 0.0001
994 DRUG DEPENDENCE 8 0.0000
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000